Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Contrary to fox7mf's negative sentiment

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Oct 12, 2023 11:14am

87 Views

Post# 35680564

RE:RE:RE:RE:RE:RE:Contrary to fox7mf's negative sentiment

You are in the misery of your own decisions. There is such an easy way out if you've lost faith. SELL!!!!

Dragging the rest of us in to your bipolar, self indulgent whinery is selfish and boring. Again, you are an enemy of all shareholders. This is a fact, you can spin it any way you like. With your daily FUD you hurt every shareholder and do the MMs dirty work.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)